title: [Recent advances in the treatment of laryngeal and hypopharyngeal carcinoma].
abstract: The prognosis of squamous epithelial cell carcinoma of the upper aerodigestive tract has improved considerably in the last 30 years. Patients presenting with stage I or II disease are treated with surgery or radiation therapy with curative intent. Although the efficacy is comparable between the two methods, surgery is usually preferred so that the side effects and late toxic effects of radiation can be avoided. For the treatment of advanced stages of disease, surgery, radiotherapy, chemotherapy and immunotherapy are usually combined. The introduction of concurrent administration of chemotherapy and radiotherapy (chemoradiotherapy) has been a major advancement. This has resulted in local control and survival rates comparable to those seen following radical surgery and postoperative radiotherapy, but with preservation of the larynx in most patients. However, recent epidemiological observations have shown declining survival rates in laryngeal cancer patients, raising concern about uncritical and too frequent use of this approach. The rationale for choosing treatment options for patients with laryngeal and hypopharyngeal carcinoma is discussed.
authors.affiliation: HNO-Abteilung, Klinikum Klagenfurt am Wörthersee, Landeskrankenhaus Klagenfurt, Feschnigstr. 11, 9026, Klagenfurt, Österreich. hans.eckel@kabeg.at
authors.forename: H E
authors.initials: HE
authors.lastname: Eckel
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D059248:Chemoradiotherapy / Q000379:methods*; D006801:Humans; D007012:Hypopharyngeal Neoplasms / Q000175:diagnosis / Q000628:therapy*; D007822:Laryngeal Neoplasms / Q000175:diagnosis / Q000628:therapy*; D013517:Otorhinolaryngologic Surgical Procedures / Q000379:methods*; D018579:Patient Selection; D020266:Radiotherapy, Conformal / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents